Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Liang Ho

Showing results (101-110 of 157) with videos related to

Pageof 16
Sort By:
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 27, 2016
CPEB4 and IRF4 expression in peripheral mononuclear cells are potential prognostic factors for advanced lung cancerYi-Ying Wu, Yi-Ting Hwang, Wann-Cherng Perng, et al.
Digital Health|December 19, 2022
Artificial intelligence-enabled electrocardiogram screens low left ventricular ejection fraction with a degree of confidenceChun-Ho Lee, Wei-Ting Liu, Yu-Sheng Lou, et al.
European Radiology|January 12, 2015
Prognostic potential of initial CT changes for progression-free survival in gefitinib-treated patients with advanced adenocarcinoma of the lung: a preliminary analysisYu-Cheng Wu, Hsian-He Hsu, Wei-Chou Chang, et al.
Oncotarget|July 16, 2016
Panels of tumor-derived RNA markers in peripheral blood of patients with non-small cell lung cancer: their dependence on age, gender and clinical stagesChih-Feng Chian, Yi-Ting Hwang, Harn-Jing Terng, et al.
The Cochrane Database of Systematic Reviews|January 4, 2024
Maintenance therapy for chronic lymphocytic leukaemiaCho-Hao Lee, Yi-Ying Wu, Tzu-Chuan Huang, et al.
Annals of Hematology|July 23, 2014
The treatment outcome of multiple myeloma patients ineligible for hematopoietic transplantation--a single institutional experience in TaiwanTzu-Chuan Huang, Jia-Hong Chen, Yi-Ying Wu, et al.
Frontiers in Oncology|July 21, 2023
Profiling of miRNAs and their interfering targets in peripheral blood mononuclear cells from patients with chronic myeloid leukaemiaSheng-Cheng Wu, Shiue-Wei Lai, Xin-Jie Lu, et al.
Plos One|March 23, 2017
Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancerWen-Yen Huang, Ching-Liang Ho, Chia-Cheng Lee, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 8, 2010
Preventing chemotherapy-induced hepatitis B reactivation in breast cancer patients: a prospective comparison of prophylactic versus deferred preemptive lamivudineShih-Hung Tsai, Ming-Shen Dai, Jyh-Cherng Yu, et al.
International Journal of Environmental Research and Public Health|May 28, 2022
Modified-Dose Pembrolizumab and Prognostic Outcomes among Non-Small Cell Lung Cancer Patients: A Chart Review StudySheng-Yin To, Li-Ting Kao, Jui-Hu Shih, et al.
Pageof 16

Showing results (101-110 of 157) with videos related to

Sort By:
Pageof 16
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 27, 2016
CPEB4 and IRF4 expression in peripheral mononuclear cells are potential prognostic factors for advanced lung cancerYi-Ying Wu, Yi-Ting Hwang, Wann-Cherng Perng, et al.
Digital Health|December 19, 2022
Artificial intelligence-enabled electrocardiogram screens low left ventricular ejection fraction with a degree of confidenceChun-Ho Lee, Wei-Ting Liu, Yu-Sheng Lou, et al.
European Radiology|January 12, 2015
Prognostic potential of initial CT changes for progression-free survival in gefitinib-treated patients with advanced adenocarcinoma of the lung: a preliminary analysisYu-Cheng Wu, Hsian-He Hsu, Wei-Chou Chang, et al.
Oncotarget|July 16, 2016
Panels of tumor-derived RNA markers in peripheral blood of patients with non-small cell lung cancer: their dependence on age, gender and clinical stagesChih-Feng Chian, Yi-Ting Hwang, Harn-Jing Terng, et al.
The Cochrane Database of Systematic Reviews|January 4, 2024
Maintenance therapy for chronic lymphocytic leukaemiaCho-Hao Lee, Yi-Ying Wu, Tzu-Chuan Huang, et al.
Annals of Hematology|July 23, 2014
The treatment outcome of multiple myeloma patients ineligible for hematopoietic transplantation--a single institutional experience in TaiwanTzu-Chuan Huang, Jia-Hong Chen, Yi-Ying Wu, et al.
Frontiers in Oncology|July 21, 2023
Profiling of miRNAs and their interfering targets in peripheral blood mononuclear cells from patients with chronic myeloid leukaemiaSheng-Cheng Wu, Shiue-Wei Lai, Xin-Jie Lu, et al.
Plos One|March 23, 2017
Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancerWen-Yen Huang, Ching-Liang Ho, Chia-Cheng Lee, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 8, 2010
Preventing chemotherapy-induced hepatitis B reactivation in breast cancer patients: a prospective comparison of prophylactic versus deferred preemptive lamivudineShih-Hung Tsai, Ming-Shen Dai, Jyh-Cherng Yu, et al.
International Journal of Environmental Research and Public Health|May 28, 2022
Modified-Dose Pembrolizumab and Prognostic Outcomes among Non-Small Cell Lung Cancer Patients: A Chart Review StudySheng-Yin To, Li-Ting Kao, Jui-Hu Shih, et al.
Pageof 16